Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet to Discuss Pivotal Study Success of Lead Program and Product Pipeline at Bank of America Merrill Lynch 2015 Animal Health Summit

DUBLIN, Ireland, Dec. 8, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced that its Chief Executive Officer, Dr. Mark Heffernan, is scheduled...
November 24, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet to Present at the 27th Annual Piper Jaffray Healthcare Conference

DUBLIN, Ireland, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced that Dr. Mark Heffernan, Nexvet's Chief Executive Officer, is...
November 16, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Announces Positive Results From NV-01 Pivotal Study in Dogs With Osteoarthritis

Primary Endpoint Achieved Conference Call November 16th at 9:00AM ET DUBLIN, Ireland, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today...
November 14, 2015 16:55 ET | Source: Nexvet Biopharma plc

Nexvet Hosting Teleconference to Provide Update on NV-01 Pivotal Study

DUBLIN, Ireland, Nov. 14, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, will host a conference call on Monday, November 16th, 2015 at 9:00 AM Eastern Time...
November 12, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Provides Speaker Update for Animal Health Symposium in New York City

DUBLIN, Ireland, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, is pleased to provide an update on its Animal Health Symposium, which is being...
November 05, 2015 06:00 ET | Source: Nexvet Biopharma plc

Nexvet Reports Financial Results for First Quarter of Fiscal Year 2016

DUBLIN, Ireland, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Veterinary biologic therapy developer Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three month period ended September...
October 19, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Initiates Pilot Field Study of NV-02 for Feline Osteoarthritis Pain

DUBLIN, Ireland, Oct. 19, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the initiation of a pilot field study for its product candidate...
October 06, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet to Host Animal Health Symposium in New York City

DUBLIN, Ireland, Oct. 6, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, is pleased to announce that it will host an Animal Health Symposium from 10:30AM to...
September 29, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Receives FY2015 Cash Refund of $3.2 Million

DUBLIN, Ireland, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced receipt of US$3.2 million in cash under the Australian Federal...
September 16, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Secures Biomanufacturing Facility and Receives IDA Ireland Support

DUBLIN, Ireland, Sept. 16, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced it has secured a dedicated biologics manufacturing facility in...